Fig. 3From: COVPRIG robustly predicts the overall survival of IDH wild-type glioblastoma and highlights METTL1+ neural-progenitor-like tumor cell in driving unfavorable outcomeA systemic review of prognostic models of IDH wild-type GBM. A Screening of previous prognostic models. B Improvement of COVPRIG in contrast to another mRNA-based externally validated model, CTSI. C Decision curves of COVPRIG and CTSIBack to article page